T Cell Dysfunction and Exhaustion in Cancer

Zhang, Zhen, Liu, Shasha, Zhang, Bin, Qiao, Liang, Zhang, Yi, Zhang, Yi·2020·Frontiers in Cell and Developmental Biology
DOI 10.3389/fcell.2020.00017

Cited by (386)

Items 101–200 of 386

  1. Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
    Erin G. Shackleton, Haleema Yoosuf Ali, Masood Ahmed Khan, Alan Graham Pockley, Stéphanie McArdle · 2021 · Cancers
  2. GLUT1 production in cancer cells: a tragedy of the commons
    Anuraag Bukkuri, Robert A. Gatenby, Joel S. Brown · 2022 · npj Systems Biology and Applications
  3. Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer
    Santhasiri Orrapin, Patcharawadee Thongkumkoon, Sasimol Udomruk, Sutpirat Moonmuang, Songphon Sutthitthasakul, Petlada Yongpitakwattana, Dumnoensun Pruksakorn, Parunya Chaiyawat · 2023 · International Journal of Molecular Sciences
  4. Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer
    Bansari A. Shah, James A. Holden, Jason C. Lenzo, Sara Hadjigol, Neil Martin O’brien-simpson · 2025 · npj Vaccines
  5. Killing the “BAD”: Challenges for immunotherapy in pancreatic cancer
    Tianjiao Li, Wenquan Wang, Xianjun Yu, Liang Liu · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  6. Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
    Nao Nagai, Yotaro Kudo, Daisuke Aki, Hayato Nakagawa, Koji Taniguchi · 2021 · International Journal of Molecular Sciences
  7. PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ flux
    Shishuo Sun, Heng Xu, Wanxin Zhao, Qihong Li, Yifan Yuan, Guopeng Zhang, Shuyu Li, Bixi Wang, Wei Zhang, Xiaoge Gao et al. · 2023 · Cancer Letters
  8. Engineered Tumor–Immune Microenvironment On A Chip to Study T Cell–Macrophage Interaction in Breast Cancer Progression
    Twinkle Jina Minette Manoharan, Kalpana Ravi, Abhirami P. Suresh, Abhinav P. Acharya, Mehdi Nikkhah · 2024 · Advanced Healthcare Materials
  9. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma
    Chaitanya Tondepu, Lohitash Karumbaiah · 2021 · Advanced Healthcare Materials
  10. Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer
    Ann Taber, Frederik Prip, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Torben Steiniche, Lars Dyrskjøt · 2022 · European Urology Oncology
  11. Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens
    Wei-Yu Chi, Yingying Hu, Hsin‐Che Huang, Hui–Hsuan Kuo, Shu‐Hong Lin, Chun-Tien Jimmy Kuo, Julia Tao, Darrell Fan, Yi-Min Huang, Annie A. Wu et al. · 2024 · Journal of Biomedical Science
  12. CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy.
    Dandan Feng, Dong-Qing Pu, Jinlu Ren, Ming Liu, Zhen Zhang, Zhiyong Liu, Jing-Wei Li · 2024 · Biochimica et biophysica acta. Reviews on cancer
  13. Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments
    Janika Härm, Yu-Tong Fan, Dirk Brenner · 2024 · Current Opinion in Immunology
  14. Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer
    Jiawen Zhang, Qinyi Zhang, Yongbin Yang, Qingying Wang · 2020 · Frontiers in Molecular Biosciences
  15. Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review)
    Xiaoran Ma, Jibiao Wu, Bin Wang, Cun Liu, Lijuan Liu, Changgang Sun · 2022 · International Journal of Oncology
  16. Allogeneic CART progress: platforms, current progress and limitations
    Ameneh Shokati, Maryam Sanjari-Pour, Mahshid Akhavan Rahnama, Saghar Hoseinzadeh, Mohammad Vaezi, Mohammad Ahmadvand · 2025 · Frontiers in Immunology
  17. Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
    Saru Basnet, Mirte van der Heijden, Dafne C.A. Quixabeira, Elise Jirovec, Susanna A.M. Grönberg-Vähä-Koskela, James H.A. Clubb, Anna Kanerva, Santeri Artturi Pakola, Lyna Haybout, Victor Arias et al. · 2024 · Molecular Therapy
  18. Senescence and Aging: Does It Impact Cancer Immunotherapies?
    Damien Maggiorani, Christian M. Beausejour · 2021 · Cells
  19. Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
    Peter Lawrence Smith, Katarzyna Piadel, Angus George Dalgleish · 2021 · Vaccines
  20. A Darwinian perspective on tumor immune evasion
    Julieann I. Puleo, Kornélia Polyák · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  21. Converging and evolving immuno-genomic routes toward immune escape in breast cancer
    Juan Blanco-Heredia, Carla Anjos Souza, Juan L. Trincado, María González‐Cao, Samuel Gonçalves-Ribeiro, Sara Ruiz Gil, Dmytro Pravdyvets, Samandhy Cedeño, Maurizio Callari, Antonio Marra et al. · 2024 · Nature Communications
  22. Targeting metabolism to improve CAR-T cells therapeutic efficacy
    Shasha Liu, Yuyu Zhao, Yaoxin Gao, Feng Li, Yi Zhang · 2024 · Chinese Medical Journal
  23. Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating Lymphocytes
    Zachary L.Z. Hay, Jennifer R. Knapp, Roman E. Magallon, Brian P. O’Connor, Jill E. Slansky · 2023 · Cancer Immunology Research
  24. Engineered Metal–Organic Frameworks for Targeted CRISPR/Cas9 Gene Editing
    Navid Rabiee, Mohammad Rabiee · 2025 · ACS Pharmacology & Translational Science
  25. Tumour-directed microenvironment remodelling at a glance
    Sarah Theresa Boyle, Mohammad Zahied Johan, Michael Susithiran Samuel · 2020 · Journal of Cell Science
  26. HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells
    Hui Guo, Cheng Zhang, Xiaotong Tang, Tiantian Zhang, Liu Yang, Hanbing Yu, Yumei Li, Rui Wang · 2022 · Inflammation
  27. Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
    Aiyuan Guo, Jingwei Zhang, Yuqiu Tian, Yun Peng, Peng Luo, Jian Zhang, Zaoqu Liu, Wantao Wu, Hao Zhang, Quan Cheng · 2022 · Frontiers in Immunology
  28. Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer
    Ho, Hsing-Ying, Chin-Hung Chen, Vincent, Tzang, Bor-Show, Hsieh, Ching-Chuan, Wang, Wen-Ke, Weng, Yi-Ping, Hsu, Ya-Ting, Hsaio, Han-Pin, Weng, Jun-Cheng, Chen, Yi-Lung · 2021 · Journal of Psychiatric Research
  29. Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma
    Sahand Saeidpour Masouleh, Kamyar Nasiri, Ava Ostovar Ravari, Mona Saligheh Rad, Kiarash Kiani, Ali Sharifi Sultani, Seyedeh Tabasom Nejati, Mohsen Nabi‐Afjadi · 2025 · Biomarker Research
  30. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8 + PD ‐1− tumor‐infiltrating T cells in PD‐L1 ‐enriched tumor microenvironment
    Ibrahim Ragab Eissa, Nobuaki Mukoyama, Mohamed Abdelmoneim, Yoshinori Naoe, Shigeru Matsumura, Itzel Bustos‐Villalobos, Toru Ichinose, Noriyuki Miyajima, Daishi Morimoto, Maki Tanaka et al. · 2021 · International Journal of Cancer
  31. Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis
    M. Mitchell, Olivier Loudig · 2023 · Biomedicines
  32. Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano‐Delivery Systems for Enhanced Immunotherapy
    Xin Huang, Weiyue Zhang · 2023 · Small Methods
  33. T cell landscape in the microenvironment of human solid tumors
    Enrico Maggi, Enrico Munari, Nadine Landolina, Francesca Romana Mariotti, Bruno Giuseppe Azzarone, Lorenzo Moretta · 2024 · Immunology Letters
  34. The Adhesome Network: Key Components Shaping the Tumour Stroma
    Pinelopi Nikolopoulou, Maria A. Koufaki, Vassiliki Kostourou · 2021 · Cancers
  35. The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies
    Fateme Sheida, Sepideh Razi, Mahsa Keshavarz‐Fathi, Nima Rezaei · 2021 · Expert Review of Anticancer Therapy
  36. Metabolic and epigenetic orchestration of (CAR) T cell fate and function
    Behnia Akbari, Zahra Hosseini, Pardis Shahabinejad, Saba Ghassemi, Hamid Reza Mirzaei, Roddy S. O’Connor · 2022 · Cancer Letters
  37. Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages
    Chanmi Jeong, Jeongdong Kim, Ik‐Hwan Han, Soyoung Kim, Ilseob Choi, Hong-Sung Kim, Jin-Hyun Jeong, Hyunsu Bae · 2023 · Frontiers in Immunology
  38. Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework
    Valentina Bruno, Martina Betti, Lorenzo D’Ambrosio, Alice Massacci, Benito Chiofalo, Adalgisa Pietropolli, Giulia Piaggio, Gennaro Ciliberto, Paola Nisticò, Matteo Pallocca et al. · 2023 · International Journal of Gynecological Cancer
  39. Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma
    Sungwoo Ahn, Noémie Leblay, Paola E. Neri · 2021 · HemaSphere
  40. Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC
    Baitul Islam, Haiyang Yu, Tian-Qi Duan, Jing Pan, Min Li, Ru-Qi Zhang, Matiullah Masroor, Ju-Fang Huang · 2023 · Journal of Biomolecular Structure and Dynamics
  41. Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints
    Dharmindra Dulal, Andrew R. Boring, David Terrero, Tiffany L. Johnson, Amit Kumar Tiwari, Dayanidhi Raman · 2023 · Cancers
  42. T-cell dysfunction in natural killer/T-cell lymphoma
    Xiaoyan Feng, Miaomiao Meng, Hongwen Li, Yuyang Gao, Wenting Song, Ruiqing Di, Zhaoming Li, Xudong Zhang, Mingzhi Zhang · 2023 · OncoImmunology
  43. The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities
    Christina S. Ennis, Pablo Llévenes, Yuhan Qiu, Ruben Dries, Gerald V. Denis · 2022 · Frontiers in Endocrinology
  44. Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy
    Aditi Mulgaonkar, Durga Udayakumar, Yaxing Yang, Shelby Freedman Harris, Orhan K. Öz, Praveen Ramakrishnan Geethakumari, Xiankai Sun · 2023 · Frontiers in Medicine
  45. Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions
    Shoham Benmelech, Thien Le, Maggie McKay, Jungmin Nam, Krupakar Venkat Subramaniam, Daniela Tellez, Grace Vlasak, Michael Mak · 2024 · APL Bioengineering
  46. Atlas-guided discovery of transcription factors for T cell programming
    H. Kay Chung, Cong Liu, Anamika Battu, Alexander N. Jambor, Brandon M. Pratt, Fucong Xie, Brian Riesenberg, Eduardo Casillas, Ming Sun, Elisa Landoni et al. · 2026 · Nature
  47. Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer
    Victor Ivanovich Seledtsov, Alexei A. von Delwig · 2020 · Expert Opinion on Biological Therapy
  48. Single-Cell Multiomics Reveals Clonal T-Cell Expansions and Exhaustion in Blastic Plasmacytoid Dendritic Cell Neoplasm
    Erica A. K. DePasquale, Daniel Ssozi, Marina Ainciburu, Jonathan Good, Jenny Noel, Martin Arreola Villanueva, Charles Couturier, Alex K. Shalek, Sary F. Aranki, Hari Reddy Mallidi et al. · 2022 · Frontiers in Immunology
  49. Mechanisms Underlying Anti-Inflammatory and Anti-Cancer Properties of Stretching—A Review
    Małgorzata Król, Patrycja Kupnicka, Mateusz Bosiacki, Dariusz Chlubek · 2022 · International Journal of Molecular Sciences
  50. Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers
    Jenny Dunn, Robert McCuaig, Abel H. Y. Tan, Wen Juan Tu, Fan Wu, Kylie M. Wagstaff, Anjum Zafar, Sayed Sahanawaz Ali, Himanshu Diwakar, Jane Esther Dahlstrom et al. · 2022 · Cancers
  51. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention
    Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, Sa’ed M. Al-dalain, Yahya M. Al-sarayra, Mansour Haddad, Hafiz Antar Makeen, Aiman Al-Qtaitat, Mohammad Hajaj Said Almermesh, Sameeh Abdulkareem Al-Sarayreh · 2023 · Biomedicines
  52. Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?
    Alexandra M. Mowday, Jella van de Laak, Zhe Fu, Kimiora L. Henare, Ludwig Jerome Dubois, Philippe Lambin, Jan Theys, Adam Vorn Patterson · 2024 · Critical Reviews in Microbiology
  53. Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future
    Han Zhang, Xinghua Lu, Binfeng Lu, Giuseppe Gullo, Lujia Chen · 2024 · Future Oncology
  54. The Mechanisms Underlying the Beneficial Impact of Aerobic Training on Cancer-Related Fatigue: A Conceptual Review
    Adeline Fontvieille, Hugo Parent-Roberge, Tamàs Fülöp, Michel Pavic, Éléonor Riesco · 2024 · Cancers
  55. CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
    Valentine De Castro, Jeanne Galaine, Romain Loyon, Yann Godet · 2024 · Cancer Gene Therapy
  56. Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma
    Zifei Wang, Yu Zhong, Zefan Zhang, Kaiqian Zhou, Zhihao Huang, Hao Nao Yu, Longqi Liu, Shiping Liu, Huanming Yang, Jian Zhou et al. · 2022 · Frontiers in Immunology
  57. Dysfunctional mitochondria in ageing T cells: a perspective on mitochondrial quality control mechanisms
    Lin Luo, Ana Victoria Lechuga‐Vieco, Clara Sattentau, Mariana Borsa, Anna Katharina Simon · 2025 · EMBO Reports
  58. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
    Yuqing Xie, Fengna Yan, Xinhui Wang, Lihua Yu, Huiwen Yan, Qing Pu, Weihong Li, Zhiyun Yang · 2022 · Cancer Medicine
  59. Activin-A impedes the establishment of CD4+ T cell exhaustion and enhances anti-tumor immunity in the lung
    Ioannis Morianos, Aikaterini Tsitsopoulou, Κonstantinos Potaris, Dimitrios Valakos, Ourania Fari, Giannis Vatsellas, Clementine Bostantzoglou, Andreas Photiades, Mina Gaga, Georgina Xanthou et al. · 2021 · Journal of Experimental & Clinical Cancer Research
  60. Viewing Cancer Through the Lens of Corruption: Using Behavioral Ecology to Understand Cancer
    Anuraag Bukkuri, Frederick R. Adler · 2021 · Frontiers in Ecology and Evolution
  61. miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling
    Madhumathy G Nair, D Apoorva, M Chandrakala, V. P. Snijesh, Sharada Patil, C. E. Anupama, Geetashree Mukherjee, Rekha V. Kumar, Jyothi S. Prabhu, Sridhar TS · 2022 · Cells
  62. Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
    Artemis Gavriil, Marta Barisa, Emma Halliwell, John Anderson · 2020 · Cancers
  63. Persistent pre-exhausted CD8+ T cells shape the tumor immune microenvironment in anaplastic thyroid cancer
    Xianhui Ruan, Mei Tao, Yuanxing Dong, Linfei Hu, Guangwei Xu, Chuanxiang Hu, Yue Huang, Yuqi Wang, Jialong Yu, Wei Feng Luo et al. · 2025 · Endocrine Related Cancer
  64. Interferons in Autoimmunity: From Loss of Tolerance to Chronic Inflammation
    Grigore Mihăescu, Grațiela Grădișteanu Pîrcălăbioru, Claudiu Natanael Roznovan, Lia-Mara Diţu, Mihaela Maria Comanici, Octavian Savu · 2025 · Biomedicines
  65. Immune cell senescence drives responsiveness to immunotherapy in melanoma
    Pavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, Panagiotis Bakouros, Sophia Magkouta, Orestis A. Ntintas, Dimitris Veroutis, Giorgos Theocharous, Ioannis V. Kostopoulos, Dimitris-Foivos Thanos et al. · 2025 · Molecular Cancer
  66. Transcriptomic reprogramming for neuronal age reversal
    Alexandru M. Pleşa, Michael Shadpour, Edward S. Boyden, George McDonald Church · 2023 · Human Genetics
  67. The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer
    Rafiq Nabi, Farhana Musarrat, Jose Cesar Menk Pinto Lima, Ingeborg Maria Langohr, Vladimir N. Chouljenko, Konstantin Gus Kousoulas · 2023 · Frontiers in Molecular Biosciences
  68. The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer
    Gino M Dettorre, M. Patel, Alessandra Gennari, George E. Pentheroudakis, Emanuela Romano, Alessio Cortellini, David James Pinato · 2021 · ESMO Open
  69. Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma
    Zuyin Li, Guohe Song, De‐Zhen Guo, Zhijie Zhou, Chen Qiu, Chao Xiao, Xiaoliang Wang, Yupeng Wang · 2022 · Journal of Cancer
  70. MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia
    Martina Del Gaizo, Ilaria Sergio, Sara Lazzari, Samantha Cialfi, Maria Pelullo, Isabella Screpanti, María Pía Felli · 2022 · International Journal of Molecular Sciences
  71. Breast cancer cell derived exosomes reduces glycolysis of activated CD8 + T cells in a AKT‐mTOR dependent manner
    Abhishek Choudhury, Soumya Chatterjee, Shauryabrota Dalui, Pronabesh Ghosh, Altamas Hossain Daptary, Golam Kibria Mollah, Arindam Bhattacharyya · 2024 · Cell Biology International
  72. Tumor-derived extracellular vesicles: Hijacking T cell function through exhaustion
    RuiJuan Guo, Ping Wang · 2025 · Pathology - Research and Practice
  73. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells
    Peter M. Sullivan, Steven James Reed, Vandana Kalia, Surojit Sarkar · 2021 · Frontiers in Immunology
  74. Degradation-resistant implanted biomaterials establish an immunosuppressive microenvironment that induces T cell exhaustion by recruiting myeloid cells
    Qin Fan, Huaxing Dai, Jinyu Bai, Jialu Xu, Qingle Ma, Ziying Fei, Xiaozhong Zhou, Kam W. Leong, Chao Wang · 2021 · Fundamental Research
  75. Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities
    Elina Kaviani, Ahmad Hosseini, Elham Mahmoudi Maymand, Mani Ramzi, Abbas Ali Ghaderi, Amin Ramezani · 2022 · PLoS ONE
  76. Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
    Nikhil H. Samarth, Pooja Gulhane, Shailza Singh · 2022 · Frontiers in Oncology
  77. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma
    Jiao Qu, Qitai Zhao, Li Yang, Yu Ping, Kai Zhang, Qingyang Lei, Fengsen Liu, Yi Zhang · 2021 · International Immunopharmacology
  78. Role of T cell exhaustion and tissue-resident memory T cells in the expression and prognosis of colorectal cancer
    Han Wu, Pei-Wen Fan, Ya-Ning Feng, Cheng Chang, Ting Gui, Jia-bei Meng, Ruozheng Wang · 2025 · Scientific Reports
  79. Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment
    Victor Ivanovich Seledtsov, Adas Darinskas, Alexei A. von Delwig, Galina Victorovna Seledtsova · 2023 · Metabolites
  80. The landscape of PBMC methylome in canine mammary tumors reveals the epigenetic regulation of immune marker genes and its potential application in predicting tumor malignancy
    A-Reum Nam, Min Heo, Kang-Hoon Lee, Ji‐Yoon Kim, Sungho Won, Je‐Yoel Cho · 2023 · BMC Genomics
  81. Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model
    Gábor J. Szebeni, Róbert Alföldi, Lajos István Nagy, Patrícia Neuperger, Nikolett Gémes, József Ágoston Balog, László Tiszlavicz, László Géza Puskás · 2023 · Vaccines
  82. Investigating Conventional and Novel Methods for Treatment of Cancer
    Zhixuan Qu · 2023 · International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB)
  83. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway
    Malvina Koni, Tatiana Lopatina, Cristina Grange, Alessandro Sarcinella, Massimo Cedrino, Stefania Bruno, Fabrizio Buffolo, Saveria Femminò, Giovanni Camussi, Maria Felice Brizzi · 2023 · Pharmacological Research
  84. Why Immunotherapy Fails in Multiple Myeloma
    Luis Gerardo Rodríguez‐Lobato, Aina Oliver‐Caldés, David Fernando Moreno, Carlos Fernández de Larrea, Joan Bladé · 2020 · Hemato
  85. Formation Pattern Analysis of Spheroids Formed by a Droplet-Based Microfluidic System for Predicting the Aggressiveness of Tumor Cells
    Sunghan Lee, Chang Jae Woo, Hyo‐Il Jung, Ki Chang Nam, Ji Seok Lim, Bongseop Kwak · 2024 · ACS Biomaterials Science & Engineering
  86. Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
    Seung Kak Shin, Yuta Mishima, Yoonseok Lee, Oh Sang Kwon, Ju Hyun Kim, Yun Soo Kim, Shin Kaneko · 2025 · Journal of Gastroenterology and Hepatology
  87. Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy
    Fayuan Wang, Weidong Chen, Yingtian Jia, Tao He, Siyi Wu, Jiahui Xiang, Rui Chen, Qingfeng Jiang, Tengjiang Yu, Yong Lan et al. · 2025 · Cancer Medicine
  88. TIMP-1 Dependent Modulation of Metabolic Profiles Impacts Chemoresistance in NSCLC
    Wei Xiao, Pankaj Kumar Ahluwalia, Lan Wang, John Harrison Howard, Ravindra B Kolhe, Amyn M. Rojiani, Mumtaz V. Rojiani · 2022 · Cells
  89. On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach
    Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tina Nehring, Katharina Pallitsch, Barbara Lieder, Marcus Hacker, Wolfgang Wadsak · 2023 · Pharmaceuticals
  90. Melatonin: a modulator in metabolic rewiring in T-cell malignancies
    Seema Rai, Gunja Roy, Younis Ahmad Hajam · 2024 · Frontiers in Oncology
  91. Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between “Foe” and “Friend” During Tumor Malignant Transformation
    Hui Tian, Baofu Zhang, Liantao Li, Gang Wang, Huizhong Li, Junnian Zheng · 2020 · Frontiers in Oncology
  92. Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment
    Sanaa Nakad Borrego, Ernst R. Lengyel, Katherine C. Kurnit · 2022 · Cancers
  93. Repeated stimulation or tonic-signaling chimeric antigen receptors drive regulatory T cell exhaustion
    Caroline Lamarche, Gherman Novakovsky, Christopher N. Qi, Evan W. Weber, Crystal Lee Mackall, Megan K. Levings · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
    Yannick Simoni, Nicolas Chapuis · 2022 · Diagnostics
  95. ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment
    Anastasia Xagara, Argyro Roumeliotou, Αlexandros Kokkalis, Konstantinos Tsapakidis, Dimitrios Papakonstantinou, Vassilis Papadopoulos, Ioannis Samaras, Evangelia Chantzara, Galatea Kallergi, Athanasios Panayotis Kotsakis · 2024 · Biomedicines
  96. Comprehensive integrated single-cell RNA sequencing analysis of brain metastasis and glioma microenvironment: Contrasting heterogeneity landscapes
    Seyedeh Fatemeh Sajjadi, Najmeh Salehi, Mehdi Sadeghi · 2024 · PLoS ONE
  97. Differential gene expression of tumor-infiltrating CD4 + T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
    Varun Sasidharan Nair, Reem Saleh, Rowaida Ziad Taha, Salman M. Toor, Khaled Murshed, Ayman Ahmed, Mohamed A. Kurer, Mohamed Abu Nada, Fares Al‐Ejeh, Eyad Elkord · 2020 · OncoImmunology
  98. Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma
    Xuming Song, Qiang Chen, Jifan Wang, Qixing Mao, Wenjie Xia, Lin Xu, Feng Jiang, Gaochao Dong · 2021 · Journal of Cellular and Molecular Medicine
  99. Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice
    Katarina Blagović, Carolyne K. Smith, Amritha Ramakrishnan, Lindsay Moore, David R. Soto, Zachary Thompson, Adam P. Stockmann, Sonia Kruszelnicki, Akshi Thakkar, Jason Murray et al. · 2022 · Frontiers in Immunology
  100. Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective
    Mehmet Sitki Copur, Geoffrey A. Talmon, Jonathan Ross Hart, Shaheed Merani, Luciano M. Vargas · 2020 · ONCOLOGY